Showing 85 to 96 of 218 results


Moderate Drinking and Obesity Double Liver Disease Risk
New research shows that even moderate alcohol consumption combined with being overweight doubles the risk of liver disease, highlighting a significant public health concern given the four-fold rise in deaths from this condition over the past two decades and the increasing number of diagnoses in thos...
Moderate Drinking and Obesity Double Liver Disease Risk
New research shows that even moderate alcohol consumption combined with being overweight doubles the risk of liver disease, highlighting a significant public health concern given the four-fold rise in deaths from this condition over the past two decades and the increasing number of diagnoses in thos...
Progress
52% Bias Score


Eli Lilly's Weight-Loss Pill Poised for Market Disruption
Eli Lilly's new weight-loss pill, showing 8% weight loss in trials, offers a more accessible treatment option compared to injectables, potentially reaching a larger patient base and generating \$100 billion in sales by 2030.
Eli Lilly's Weight-Loss Pill Poised for Market Disruption
Eli Lilly's new weight-loss pill, showing 8% weight loss in trials, offers a more accessible treatment option compared to injectables, potentially reaching a larger patient base and generating \$100 billion in sales by 2030.
Progress
64% Bias Score


High Rates of Hypertension and Obesity Among Older Adults in Mecklenburg-Vorpommern
In Mecklenburg-Vorpommern, Germany, hypertension is the most common age-related illness, affecting one in three 60-69 year-olds, rising to four in five by age 70-79 and nine in ten by 80-89. The state also has the highest obesity rate in Germany for the 60-79 age group (10.7% and 24.7% respectively)...
High Rates of Hypertension and Obesity Among Older Adults in Mecklenburg-Vorpommern
In Mecklenburg-Vorpommern, Germany, hypertension is the most common age-related illness, affecting one in three 60-69 year-olds, rising to four in five by age 70-79 and nine in ten by 80-89. The state also has the highest obesity rate in Germany for the 60-79 age group (10.7% and 24.7% respectively)...
Progress
40% Bias Score


India's Soaring Obesity Crisis: Abdominal Fat Poses Major Health Threat
India faces a rapidly escalating obesity crisis, with 180 million adults currently overweight or obese—a number projected to reach 450 million by 2050. Abdominal obesity, linked to insulin resistance and chronic diseases, is particularly prevalent, affecting nearly 40% of women and 12% of men. New c...
India's Soaring Obesity Crisis: Abdominal Fat Poses Major Health Threat
India faces a rapidly escalating obesity crisis, with 180 million adults currently overweight or obese—a number projected to reach 450 million by 2050. Abdominal obesity, linked to insulin resistance and chronic diseases, is particularly prevalent, affecting nearly 40% of women and 12% of men. New c...
Progress
40% Bias Score


UK Junk Food Ads Surge Before New Regulations
UK food companies spent an extra £420m on advertising in 2024, a 26% increase, coinciding with a rise in sales of unhealthy snacks before new regulations curb TV and online ads from October, leaving loopholes for other forms of advertising.
UK Junk Food Ads Surge Before New Regulations
UK food companies spent an extra £420m on advertising in 2024, a 26% increase, coinciding with a rise in sales of unhealthy snacks before new regulations curb TV and online ads from October, leaving loopholes for other forms of advertising.
Progress
52% Bias Score


Severe Obesity Linked to Increased Risk of 16 Diseases
A Johns Hopkins University study of 270,657 people reveals that severe obesity drastically increases the risk of 16 common diseases, including sleep apnea, type 2 diabetes, and fatty liver disease, with risks increasing proportionally to BMI.
Severe Obesity Linked to Increased Risk of 16 Diseases
A Johns Hopkins University study of 270,657 people reveals that severe obesity drastically increases the risk of 16 common diseases, including sleep apnea, type 2 diabetes, and fatty liver disease, with risks increasing proportionally to BMI.
Progress
52% Bias Score

Rising Cancer Deaths in the U.S. Despite Overall Decline
A new report reveals that while overall cancer deaths are declining in the U.S., deaths from several cancers—including melanoma, oral cancers, and those affecting bones, joints, pancreas, uterus, and liver—are increasing due to factors such as obesity, delayed diagnosis, and an aging population.

Rising Cancer Deaths in the U.S. Despite Overall Decline
A new report reveals that while overall cancer deaths are declining in the U.S., deaths from several cancers—including melanoma, oral cancers, and those affecting bones, joints, pancreas, uterus, and liver—are increasing due to factors such as obesity, delayed diagnosis, and an aging population.
Progress
20% Bias Score

Australian MP Advocates for Men's Health, Discloses Weight-Loss Medication Use
Australian Member of Parliament Dan Repacholi publicly discussed his use of Mounjaro, a weight-loss drug, highlighting a need for open conversation about men's health and advocating for its inclusion in the Pharmaceutical Benefits Scheme to lower costs.

Australian MP Advocates for Men's Health, Discloses Weight-Loss Medication Use
Australian Member of Parliament Dan Repacholi publicly discussed his use of Mounjaro, a weight-loss drug, highlighting a need for open conversation about men's health and advocating for its inclusion in the Pharmaceutical Benefits Scheme to lower costs.
Progress
44% Bias Score

Metabolic Syndrome Significantly Increases Breast Cancer Recurrence and Mortality Risk
A study of over 42,000 breast cancer patients revealed that metabolic syndrome increases breast cancer recurrence risk by 69% and mortality risk by 83% in survivors, highlighting the need for metabolic screening and lifestyle interventions.

Metabolic Syndrome Significantly Increases Breast Cancer Recurrence and Mortality Risk
A study of over 42,000 breast cancer patients revealed that metabolic syndrome increases breast cancer recurrence risk by 69% and mortality risk by 83% in survivors, highlighting the need for metabolic screening and lifestyle interventions.
Progress
24% Bias Score

Sirona Weight-Loss Pill Shows Promising Results in NHS Trial
A new weight-loss pill, Sirona, currently in NHS trials, shows obese patients losing an average of 3.6kg (7.9 lbs), or roughly 10%, of their body weight in 12 weeks with no reported side effects, unlike other treatments like Ozempic and Xenical.

Sirona Weight-Loss Pill Shows Promising Results in NHS Trial
A new weight-loss pill, Sirona, currently in NHS trials, shows obese patients losing an average of 3.6kg (7.9 lbs), or roughly 10%, of their body weight in 12 weeks with no reported side effects, unlike other treatments like Ozempic and Xenical.
Progress
52% Bias Score

Lifestyle Factors Contribute to Nearly Half of U.S. Cancer Cases and Deaths
A study published in an American Cancer Society journal found that nearly 40% of adult cancers and 44% of cancer deaths in the U.S. are attributable to lifestyle factors, with smoking, excess body weight, and alcohol consumption being the primary contributors.

Lifestyle Factors Contribute to Nearly Half of U.S. Cancer Cases and Deaths
A study published in an American Cancer Society journal found that nearly 40% of adult cancers and 44% of cancer deaths in the U.S. are attributable to lifestyle factors, with smoking, excess body weight, and alcohol consumption being the primary contributors.
Progress
40% Bias Score

Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand Medicare and Medicaid coverage of expensive anti-obesity drugs, citing fiscal concerns and the need for further review, impacting millions of Americans and leaving access to these medications limited.

Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand Medicare and Medicaid coverage of expensive anti-obesity drugs, citing fiscal concerns and the need for further review, impacting millions of Americans and leaving access to these medications limited.
Progress
52% Bias Score
Showing 85 to 96 of 218 results